key: cord-0036594-uj1vby14
authors: Li, HongJun; Li, Li; Ren, Meiji; Dai, Jie
title: Influenza A (H1N1)
date: 2015-04-30
journal: Radiology of Infectious Diseases: Volume 1
DOI: 10.1007/978-94-017-9882-2_22
sha: 7cf6cdd262bea71e9e3665a1d8316b0cade842c9
doc_id: 36594
cord_uid: uj1vby14

Influenza A (H1N1) is an acute respiratory infectious disease caused by mutant influenza A virus subtype H1N1. The pathogen is a new virus emerging after virus gene recombination of swine influenza, avian influenza, and human influenza. Influenza A (H1N1) is transmitted commonly via respiratory droplets and direct or indirect contact. Clinically, influenza A (H1N1) is characterized by influenza-like symptoms such as fever, cough, and rhinorrhea. But in rare serious cases, the condition may progress rapidly, with occurrence of viral pneumonia, respiratory failure, and multiple organ failure. Even death occurs in serious cases, with a mortality rate of 23–25 %. On April 30, 2009, influenza A (H1N1) was officially listed into Class B infectious diseases in China. Since then, it has been managed according to the Infectious Disease Prevention and Control Act in China. Meanwhile, it has been introduced into the category of quarantinable infectious disease for management based on the Frontier Health and Quarantine Law of China.

Infl uenza A (H1N1) virus belongs to the family of Orthomyxoviridae , the species of infl uenza A (H1N1) virus. The typical virus particle is an enveloped sphere with a diameter of 80-120 nm. On the envelope, there are many glycoprotein protrusions arrayed radially, including column-like hemagglutinin (HA), mushroom-shaped neuraminidase (NA), and matrix protein M2. A symmetrically spiral nucleocapsid is inside the virus envelope, with a diameter of 10 nm and ringlike structures in both ends. As a new mutant, infl uenza A (H1N1) virus is a single-negative-stranded RNA with a genome weighing about 13.6 kb. The virus strain of infl uenza A (H1N1) is the result of recombined eight gene fragments of infl uenza virus in different sizes, including HI, NP, and NS from classical swine infl uenza virus, PB2 and PA from avian infl uenza virus in North America, PB1 from human infl uenza A (H3N2) virus, and N1 and M from swine infl uenza virus in Europe and Asia. A scholarly study on ferret models was reported to have fi ndings that infl uenza A (H1N1) virus is more pathogenic than seasonal infl uenza virus because it survives in the small intestine while seasonal infl uenza virus fails to. Infl uenza A (H1N1) virus is sensitive to common disinfectants such as ethanol, iodophor, and tincture of iodine and can be inactivated by oxidant, olefi n acid, halogen compounds, and calcium oxychloride. Infl uenza A (H1N1) virus is heat intolerable, which can be inactivated at a temperature of 56 °C for 30 min. Its infectivity can be rapidly destructed by direct sunlight for 40-48 h or ultraviolet radiation.

In March 2009, an outbreak of human-infected swine infl uenza occurred in Mexico, with following rapid spread worldwide. The WHO initially nominated the disease as human-infected swine infl uenza, which is renominated as infl uenza A (H1N1) later. By mid-June 2009, the cases of infl uenza A (H1N1) have been reported in 74 countries and regions across the world, with a total of 28,744 reported cases including 144 cases of deaths. At that time, the WHO upgraded the warning level of infl uenza to 6 again to declare a pandemic of infl uenza in the world. By August 6, 2010, the cases of infl uenza A (H1N1) have been reported in 214 countries, with a total of 18,449 reported cases of death.

In mainland China, the fi rst imported case of infl uenza A (H1N1) was reported on May 11, 2009 . During May to August in 2009, the reported cases of infl uenza A (H1N1) are more commonly imported, with a low level of prevalence. However, since the end of August 2009, the prevalence of infl uenza A (H1N1) in mainland China progresses rapidly, with a widespread that is predominantly outbreaks in schools.

In early December 2009, its prevalence reached its peak, with following decline of reported new cases. In early January 2010, the prevalence of infl uenza A (H1N1) is close to its prevalence level during the same period of the previous years. By March 31, 2010, a total of above 127,000 cases of defi nitively diagnosed infl uenza A (H1N1) had been reported in 31 provinces of China, including 126,000 cases of domestic infection and 1,228 imported cases. A total of 122,000 cases had been cured, with 4,859 cases receiving therapies in hospitals, 46 cases being treated at home, and 800 cases of death.

The main source of infection is patients with infl uenza A (H1N1), and asymptomatic patients are also infectious. No evidence has been found to prove infection of humans from animals. After the infection, an incubation period usually lasts for 2-7 days. Most patients discharge viruses during the period from 1 day prior to the onset of the disease to 5-7 days after its onset or to the day prior to the absence of symptoms. Patients of young children and individuals with compromised immunity or serious symptoms might have a longer period of infectivity.

Infl uenza A (H1N1) is mainly transmitted along with droplets via the respiratory tract. Sometimes, it also spreads via direct or indirect contact of the mucosa at the mouth, nose, and eyes. Contacts to respiratory secretions and body fl uids from patients with infl uenza A (H1N1) or to contaminated utensils might also cause infection. The route of transmission along with aerosol via the respiratory tract needs further evidence to be proved.

Populations generally susceptible to infl uenza A (H1N1) are those who lack antibodies to fi ght against this new virus mutant. Most patients are at the age of 25-45 years, predominantly young adults and occasionally elderly people and children.

In the reported severe cases earlier, patients aged 19-49 years account for 35 %, indicating that severe infl uenza A (H1N1) commonly occurs in young adults. Most experts believe that the high-risk populations of severe infl uenza A (H1N1) include pregnancies, especially those infected in the fi rst 3 months during pregnancy, children under the age of 2 years, and patients with chronic pulmonary diseases.

According to the guideline of infl uenza A (H1N1) (2010 edition) issued by the Ministry of Health in China, the following populations tend to develop severe infl uenza A (H1N1) after the occurrence of infl uenza-like symptoms:

1. Pregnancies 2. Patients with the following diseases or conditions: chronic respiratory diseases, cardiovascular diseases (with hypertension excluded), renal diseases, hepatic diseases, blood disorders, neurological diseases and neuromyopathies, metabolic disturbance and endocrinopathies, immunosuppression (including individuals using an immune suppressor or with immunodefi ciency due to HIV infection), long-term use of aspirin, and under the age of 19 years 3. Obese persons with a body weight index exceeding 30 4. Children under the age of 5 years, especially children under the age of 2 years 5. The elderly people aged above 65 years For these fi ve populations with infl uenza-like symptoms, focused attention should be paid clinically. They should receive immediate detection for nucleic acids of infl uenza A (H1N1) virus and other necessary examinations.

According to a report by the WHO, the cases with defi nitive diagnosis of infl uenza A (H1N1) are commonly young adults all over the world, with its incidence rates in males and females being close to 1:1.

The prevalence of infl uenza A (H1N1) occurs globally in 214 countries and regions, with serious prevalence in both southern and northern hemispheres. Initial studies have demonstrated that during the early period of global prevalence, the severity of prevalence is related to airline transportations in Mexico. During the disseminating period of the prevalence, the early regional distribution of infl uenza A (H1N1) is related to the communication frequency with the epidemic foci.

In May 2009, infl uenza A (H1N1) rapidly spreads worldwide, with a peak prevalence in July in the southern hemisphere and a peak prevalence in October and November in the northern hemisphere.

Infl uenza A (H1N1) virus contains α-2,6-sialic acid glycosides and α-2,3-sialic acid glycosides. After its infection to the human body, it can replicate in epithelial cells of the whole respiratory tract to invade bronchi, bronchioles, and alveolar epithelial cells in large quantities. The hemagglutinin binds to the sialic acid on the surface of cells to invade the cells, with following replication of genetic materials in a large quantity to produce viral proteins. The cell membrane envelopes the genetic materials of the virus and viral protein, giving rise to another sphere from the cell-like budding. The new virus adheres to the cell via the bond between hemagglutinin and sialic acid. After that, neuraminidase hydrolyzes the sialic acid to release the new virus from its host cell and the released new virus can invade another cell. By autopsy of the death cases from infl uenza A (H1N1), the pathological examination of the pulmonary tissues demonstrated extensive epithelial degeneration and necrosis of bronchi and bronchioles as well as exudates containing neutrophils and monocytes fi lling the bronchi, bronchioles, and alveoli. The critical factors determining the onset and development of infl uenza A (H1N1) include the loading dose of infl uenza A (H1N1) virus, the intrapulmonary infi ltration of the infl ammatory cells, and the release of infl ammatory mediators. The early animal studies about infl uenza A (H1N1) virus collected in 1918 have demonstrated infi ltration of large quantities of neutrophils and macrophages in rat pulmonary tissues, waterfall-like releases of enzymes and cytokines (including IFN-α, IFN-γ, TNF-α, MIP-1α, and MIP-2) by infl ammatory cells, and mutually enhanced pathological effects by cytokines and infl ammatory cells. Consequently, pulmonary lesions, pulmonary dysfunction, decreased body weight, and general fatigue occur. The studies on animals inoculated with HA DNA infl uenza virus vaccine indicated that the increase of released IFN-γ is more than the released IL-4 and the replication of infl uenza A (H5N1) virus declines, both of which have quantityeffect relationship with the amount of vaccines. These fi ndings indicated that the immune reactions against infl uenza virus infection have bias on Th cellular immune reactions and the production of cytokine Th2 is related to large quantity replications of infl uenza virus. By clinical trials, it has been found that strong cytokine IRF-3 reaction can reduce IFN-β, IFN-λ1, and MCP-1 and partially reduce TNF-α, which is related to the severity of infl uenza A (H5N1) symptoms and viral replication. Recent studies have demonstrated that the virus-induced cytokine (IFN, TNF-α) reactions are even weaker than seasonal infl uenza despite the differences of genotypes and antigenicity between infl uenza A (H1N1) and seasonal infl uenza. The relationship between the weaker virus-induced cytokine reactions and mild clinical manifestations of infl uenza A (H1N1) remains elusive. The susceptibility of young adults is possibly caused by serious damages to the autoimmune balance and tissues resulted from more released infl ammatory mediators by immune cells due to more sensitive immunity in young adults and thus the more intense immune responses after infection of infl uenza A (H1N1) virus.

Infl uenza A (H1N1) virus spreads via the respiratory tract, with alveoli as its target cells. In the early stage of infection, diffuse infl ammations cause laryngeal, tracheal, and bronchial edema and infl ammatory cell infi ltration that is predominantly lymphocytes and histiocytes. Necrotizing tracheobronchitis occurs following the shedding of ciliated columnar epithelium in the bronchi, with ulcerations and shedding of bronchial mucosa. There are alveolar capillary congestion and alveolar hemorrhage, with the alveolar lumens fi lled with liquid exudates of fi brins. Alveolar edema and fusion of substantial lobular infl ammatory exudates occur in alveoli lined with transparent pneumonocytic membrane. With the progress of the conditions, pulmonary interstitial tissues are involved, with reduced alveolar gas content, pulmonary consolidation, and fi brosis. Li et al. reported that pulmonary diffuse fi brosis and alveolar lesions occur in the serious and critical cases, with alveolar edema and substantial lobular infl ammatory exudates. With the progress of the conditions, pulmonary interstitial tissues are involved, with reduced alveolar gas content as well as pulmonary hemorrhage, consolidation, and fi brosis. H&E staining showed widened septum between alveolar walls, congested alveolar walls, infi ltration of neutrophils and plasmocytes that are mostly monocytes, and exudation of edema liquid and celluloses within alveoli.

In China, most cases of infl uenza A (H1N1) can be categorized into the mild type, with lesions confi ned in the upper respiratory tract and possible complication of mild lobular pneumonia. The serious and critical cases are rare, with manifestations of necrotizing tracheobronchitis and diffuse alveolar lesions.

The incubation period of infl uenza A (H1N1) generally lasts for 1-7 days, being 1-3 days in most cases.

The early symptoms of infl uenza A (H1N1) are similar to those of infl uenza. It has an acute onset, with symptoms of fever, pharyngalgia, rhinorrhea, nasal obstruction, cough and expectoration, headache, general soreness and pain, and fatigue. But in some cases, vomiting and/or diarrhea may occur. In rare cases, only slight upper respiratory symptoms occur without fever. The signs commonly include congestive pharynx and swollen tonsils.

The cases of newborns and infants have atypical symptoms, with manifestations of low-grade fever, drowsiness, diffi culty feeding, tachypnea, apnea, cyanosis, and dehydration. Children may have wheezing. In some cases of children, symptoms involving the central nervous system can be found.

Compared to nonpregnant women and common populations, tachypnea is more common in pregnant women after the infection of infl uenza A (H1N1). The cases of pregnant women are more susceptible to pneumonia and respiratory failure. Some pregnancy-related special symptoms might occur due to fever or complications of pneumonia or septic shock. Their symptoms include irregular uterine contraction, bloody vaginal secretion, and other symptoms of threatened labor. And these manifestations may even induce premature birth and fetal distress in the uterus. Infl uenza A (H1N1) may exacerbate the underlying basic diseases, with corresponding clinical manifestations.

In rare cases, infl uenza A (H1N1) rapidly progresses with occurrence of secondary diseases, such as severe pneumonia, acute respiratory distress syndrome, pulmonary hemorrhage, pleural effusion, pancytopenia, renal failure, septicemia, shock and Reye syndrome, respiratory failure, and multiple organ dysfunction or failure. Children may develop central nervous system complications.

Infl uenza A (H1N1)-related acute neurological complication is defi ned as convulsion, encephalopathy, or encephalitis occurring in the fi rst 5 days after the onset of infl uenza-like symptoms, with laboratory evidence of infl uenza A (H1N1) virus infection of the respiratory tract but no evidence of any other infections.

Encephalopathy is defi ned as changes of consciousness including irritation, lethargy, or coma for over 24 h. The cases with concurrent symmetric bilateral thalamic necrosis are diagnosed as having acute necrotizing encephalopathy (ANE).

Encephalitis refers to the occurrence of the following two or more manifestations based on encephalopathy: (1) fever with a body temperature above 38.5 °C, (2) physical signs of focal neuropathies, (3) increased lymphocytes in the cerebrospinal fl uid, (4) encephalitis indicated by electroencephalography, and (5) infection or infl ammation indicated by neuroimaging. The fi rst report of infl uenza A (H1N1)-related neurological complications was published in the United States. The reported cases included four boys aged 7-17 years, three having encephalopathy and one having convulsion. Their manifestations are mild and all are cured. Thereafter, a death case from infl uenza A (H1N1)-related ANE was reported in the United States, being a girl aged 12 years with a past history of good health. In China, three cases of death from infl uenza A (H1N1)-related ANE were reported in Shenzhen Children's Hospital, Guangdong.

Child cases of infl uenza A (H1N1)-related neurological complications commonly have clinical manifestations of drowsiness, irritation, convulsion, and coma. These symptoms commonly occur in 1-4 days after the occurrence of acute fever with/without accompanying respiratory tract symptoms. The rarely found symptoms include temporary blindness and inappropriate laughter.

Acute necrotizing encephalopathy (ANE) is a rare but severe complication of the central nervous system (CNS) following viral infection. Such cases are mostly caused by infl uenza virus and rarely caused by parainfl uenza virus, human herpesvirus 6, or other viruses. ANE was fi rstly reported by Mizuguchi et al. in 1995, and such cases have been commonly reported in Japan and Chinese Taiwan, which has been rarely reported in other countries and regions.

The clinical manifestations of ANE are similar to other acute encephalopathies. About 90 % of children develop prodromal symptoms such as fever and acute upper respiratory tract infection before the occurrence of acute encephalopathy.

Clinically, it is characterized by multifocality and symmetric brain lesions, involving the bilateral thalamus, brainstem tegmentum, white matter around cerebral ventricles, and cerebellar medulla. The cerebrospinal fl uid examination shows no other abnormalities but a slight increase of proteins. In some cases, there are increased hepatic transaminase and myocardial enzymes. Increased blood ammonia is rarely found and the level of blood glucose is normal. The mortality rate of ANE in the acute stage reaches as high as 30 % and most survivors are compromised by severe neurological sequelae.

The pathological mechanism underlying ANE has not been well defi ned. Participation of virus infection-induced cytokines in the mediation might play a role, which is mainly related to IL-6 and TNF-α. Focal vascular lesions induce destruction of the blood-cerebrospinal fl uid barrier and exudation of blood plasma, leading to cerebral edema, spots of hemorrhage, and necrosis of neurons and gliocytes. The gross pathological changes include brain tissue malacia and accompanying partial tissues lysis, occurring predominantly in the thalamus, white matter of the deep cerebrum, tegmentum of the brainstem, and white matter in the deep cerebellum. Histological sections show fresh necrotic foci, with no reactive hyperplasia of astrocytes and microglia and no infi ltration of infl ammatory cells.

Infl uenza A (H1N1)-related pneumonia demonstrates pulmonary infi ltrative lesions or pulmonary consolidation by chest X-ray or CT scanning. Hospital-acquired pneumonia and ventilator-associated pneumonia should be excluded.

The WBC count is commonly normal or decreased. In some serious cases in children, total WBC count may increase.

In some cases, hypokalemia can be found. But in rare cases, the levels of creatine kinase (CK), aspartate transaminase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) increase.

Detection of Virus Nucleic Acid RT-PCR, or favorably real-time RT-PCR, can be used for genetic detection of the respiratory tract specimens such as pharyngeal swab, nasal swab, suctions from the nasopharynx or trachea, and sputum and for molecular epidemiological survey. The FDA and CDC in the United States recommend ABI quantitative PCR for detection of infl uenza A (H1N1) virus due to its advantages of being rapid with high sensitivity and specifi city.

Infl uenza A (H1N1) virus can be isolated from respiratory tract specimens.

Dynamic detection of double sera for specifi c antibody against infl uenza A (H1N1) virus shows at least four times increase of the antibody level.

X-ray has advantages of being economical and convenient, which is the radiological examination of choice for initial diagnosis and following examinations. Bedside X-ray radiography is convenient and fast for dynamic observation of the pulmonary infections. Quarantine with bedside X-ray is also convenient if necessary.

CT scanning has high resolution to distinguish tissues, which has higher sensitivity to early mild pathological changes, ground-glass-like shadows, and pulmonary interstitial lesions. These advantages facilitate in fi nding lesions in the posterior costophrenic angle area and overlapping areas between heart shadow and aorta shadow. Routine CT scanning generally should be followed by HRCT scanning.

MR imaging is commonly applied for the diagnosis of infl uenza A (H1N1)-related neurological complications.

Brain CT scanning may demonstrate no obvious abnormalities in the early stage of the conditions. However, in the middle and advanced stages of the conditions, brain CT scanning demonstrates deepened cerebral sulcus, enlarged cerebral ventricles, and other atrophic changes of the cerebrum. By follow-up examinations, brain CT scanning of the cured cases demonstrates no abnormalities.

In the early stage of the condition, diffuse cerebral edema may be demonstrated by CT scanning. Tang et al. reported two cases of early cerebral edema with demonstrations of rapid progress of the condition into cerebromalacia and cerebral liquefaction by reexaminations in a short period of time. Of the two cases of death, one was accompanied by cerebral hemorrhage, and the occurrence of death indicated poor prognosis in the patients with early cerebral edema. The demonstrations also included low-density foci in the cortex and subcortical tissue of the cerebellar hemisphere and cerebral hemisphere and in the centrum ovale (Figs. 22.1 and 22.2 ) . Kong et al. reported one case of infl uenza A (H1N1)-related neurological complication. The CT scanning demonstrations included multiple patches of low-density foci in the cortex and subcortical tissues of the bilateral cerebellar hemisphere and cerebral hemisphere. These foci have unclearly defi ned boundaries, which are more obvious in the parietal lobe. The foci of this case were demonstrated to have rapid changes. By reexamination after 2 days, the density of foci slightly decreased. And by reexamination after 7 days, the foci obviously reduced in quantity.

A boy aged 2.5 years complained of fever and cough for 3 days. By physical examinations, T 39.7 °C and bpm 130/min. He had rough breathing sound in both lungs with a large quantity of moist rales. And he had no defi nitive history of contacts to patients with infl uenza A 

MR imaging demonstrates diffuse demyelination in the cerebellar hemisphere, brainstem, and white matter of the cerebrum. Contrast imaging demonstrates patches of enhancement and gyrus enhancement in different sizes in the cerebellar hemisphere, brainstem, and parenchyma of the cerebral hemisphere. Haktanir reported one case of meningoencephalitis, with demonstrations of high signal by T2WI in the bilateral frontoparietal interfaces and thalamus. Contrast T1WI demonstrates obvious enhancement of the right frontoparietal interface and enhancement of meninges in bilateral cerebral hemispheres. Susceptibility weighted imaging of T2FFE demonstrates more obvious high signal in the right frontoparietal interface, with no cerebral edema. Symmetric cerebral multiple foci are a characteristic manifestation of ANE, which can be well demonstrated by CT scanning and MR imaging. The foci are commonly found in the thalamus, tegmentum of the brainstem, white matter surrounding the lateral ventricles, and cerebellar medulla. CT scanning demonstrates symmetric low density in the bilateral thalamus, posterior limb of internal capsule, brainstem, and white matter of bilateral frontal, parietal, and occipital lobes. There are diffuse cerebral edema, absence of the sulcus and the fourth ventricle, and possible brainstem edema. Bilateral basal ganglia infarction has been also reported. MR imaging demonstrates symmetric long T1 and long T2 signals in the bilateral thalamus, basal ganglia, brainstem, splenium of the corpus callosum, bilateral centrum ovale, and paraventricular white matter, which are also high signals by FLAIR. Contrast imaging demonstrates linear and ring-shaped enhancement of the centrum ovale and thalamus but no abnormal enhancement of meninges. DWI demonstrates high signal in the bilateral thalamus or low central signal, boundary ring-shaped high signal, and high signal of other lesions. ADC image demonstrates slightly higher central signal surrounded by ring-shaped lower signal (low value of ADC). Cerebellar involvement is demonstrated as slightly long T1 and slightly long T2 signal in the bilateral cerebellar medulla and in the right cerebellar middle peduncle, which are in slightly high

A female patient aged 20 years complained of fever and cough for 4 days as well as headache and conscious disturbance for 1 day. By physical examination, T 40 °C, bpm 128/min, R 25/min, BP 108/58 mmHg, and SPO 2 95 %. She was in coma with no response to calling. Her respirations were sobbing-like, with positive cervical resistance and negative meningeal irritation sign. She also had congestive pharynx, occasional moist rales in both lungs, positive bilateral Babinski sign, and positive Chaddock sign. By laboratory tests, she was positive for viral nucleic acid of infl uenza A (H1N1). By routine blood tests, WBC 39.6 × 10 9 /L and GR% 92.4 %. By blood biochemistry, UA 676 μmol/L, CK 1482 U/L, CK-MB 347 U/L, and HBDH 1294 U/L. Death occurred due to shock complicated by DIC and multiple organ failure of the brain, lungs, heart, liver, and kidneys as well as critical infl uenza A (H1N1) complicated by virus meningoencephalitis. signal by FLAIR and high signal by DWI. Contrast imaging demonstrates obvious enhancement of cerebellar meninges. Compared to traditional sequences, DWI more favorably demonstrates pathological changes, with complex signal changes. DWI demonstrates low signal at the lesion centers in the bilateral thalamus whose pathological basis is necrosis of nerves and gliocytes and surrounding ring-shaped high signal whose pathological basis is cytotoxic edema and limited movement of water. ADC image demonstrates low signal in the center of the thalamus with surrounding high signal and elevated ACD value due to vasogenic edema (Figs. 22.3 , 22.4 , and 22.5 

A boy aged 3 years complained of fever and wheezing for 6 days. He also suffered from cough, expectoration, and wheezing after physical activities. Shuanghuanglian mixture was given for 1 day, with following exacerbation of the above symptoms and accompanying dyspnea. At day 6 after the onset, pharyngeal swab was positive. It was reported that several children experienced fever in the kindergarten the boy went. By physical examination, T 39 °C, bpm 118/min, and tonsillar enlargement in fi rst degree was found. The respiration sound of both lungs was rough, with fi ne moist rales in the left lower lung and large quantity wheezing sound in the right lung. Pharyngeal swab by CDC demonstrated positive M gene of infl uenza A (H1N1) virus, positive NP gene of swine infl uenza virus, and positive HA gene of infl uenza A (H1N1) virus. By routine blood test, WBC 9.73 × 10 9 /L, GR% 30.64 %, and LY% 31.14 %. By blood biochemistry, AST 42 U/L, ALT 21 U/L, and LDH 274 U/L. 

Pediatric infl uenza A (H1N1) complicated by pneumonia has no characteristic chest radiological demonstrations and dynamic changes in its early stage, with no obvious differences from common lung infections. In the progressing stage, parenchymal lesions are more common, possibly with complications of ARDS and mediastinal emphysema. And in the absorption stage, pulmonary interstitial lesions are more common, with blurry pulmonary markings, poor transparency of bilateral lungs, and heterogeneous lung infl ation.

Pulmonary parenchymal lesions are characterized by infi ltrative shadows of pulmonary parenchyma that are commonly bilateral. Some studies demonstrated more common unilateral involvement than bilateral involvement, with more commonly found involvement of the right lung. The lesions are mainly located in the inner middle zone, with possible involvement of upper, middle, and lower lung fi elds. The involvement of middle and lower lung fi elds is more common. However, some scholarly studies demonstrated more commonly found lesions in the basilar part of the lungs. Parenchymal infi ltration may be characterized by single or multiple small patches of shadows, which can fuse into large fl akes of shadows and/or ground-glass opacity (GGO) (Figs. 22.6 , 22.7 , 22.8 , and 22.9 ) . In children, the lesions are commonly demonstrated as patches of shadows, while in infants and young children, the lesions are commonly demonstrated as cotton-wool opacity.

Pulmonary interstitial lesions are characterized by increased, thickened, and blurry pulmonary vascular markings, with grids shaped and nodular shadow of different degrees ( Fig. 22 .10 ). Some scholars put forward that in the early stage, X-ray of children demonstrates no interstitial changes, which might be related to the limitations of X-ray and the course of illness.

In the severe cases, there are also demonstrations of increased pulmonary markings and excessive infl ation. The causes may be the involved major airway due to perivascular lesions of the bronchi. The following necrosis of the bronchial wall and the infi ltration of neutrophils cause obstruction of the small airway, leading to excessive alveolar infl ation.

In some cases, there are also demonstrations of involvement of the pleura, pleural effusion, mediastinal lymphadenectasis, and hilar lymphadenectasis.

A foreigner girl aged 12 years complained of fever and cough for 2 days. She also complained of accompanying chills, aversion to cold, and pharyngalgia. She had a history of contact to patients with infl uenza A (H1N1 

A boy aged 12 years complained of cough and expectoration for 2 weeks that progresses with accompanying fever for 3 days. He also complained of fatigue, poor appetite, rhinorrhea, and muscular soreness and pain. By physical examinations, T 39.8 °C, the pharynx was congested, and no tonsillar enlargement was present. He had a history of contact to patients with infl uenza A (H1N1 

Demonstrations of CT scanning are basically the same as those by chest X-ray, including increased, thickened, and blurry pulmonary markings and small fl akes of parenchymal shadows distributing along the bronchial tree in the lungs. Sometimes, the small fl akes of parenchymal shadows may be large fl akes of consolidations, with ground-glass opacity around the lesions. In addition, heterogeneous infl ation and spots of interstitial changes can be found (Figs. 22.11 , 22.12 , and 22.13 ). In the severe pediatric cases, excessive pulmonary infl ation may be found. CT scanning has advantages in clearly defi ning diseased pulmonary segments and lobes, slight pleural reaction, and small quantities of pleural effusion.

A boy aged 2.5 years complained of fever and cough for 8 days. He received medications of cephalosporin antibiotics and Shuanghuanglian mixture for 2 days, with no improvement and with poor appetite, exacerbated cough, depression, and perleche. Pharyngeal swab was positive at day 9 after the onset. He had an unclearly defi ned history of contact to patients with infl uenza A (H1N1). By physical examinations, T 38.7 °C, bpm 13/min, and per-leche and scattering white spots were found in the oral mucosa. He had rough breathing sound in both lungs and a large quantity of moist rales in 

A boy aged 12 years complained of fever and cough for 5 days with whitish phlegm and a body temperature of 39.7 °C. After anti-infection therapy for 4 days, his conditions failed to improve, with a body temperature above 39 °C. Pharyngeal swab at day 5 after the onset was positive. By physical examination, tonsillar enlargement in fi rst degree was found and rough breathing sound was heard in both lungs. He had a history of close contact to patients with infl uenza A (H1N1 

A boy aged 15 years complained of fever for 4 days as well as cough, shortness of breath, and dyspnea for 3 days. He also complained of dizziness, pharyngalgia, nasal obstruction, rhinorrhea, and cough with yellowish thick sputum diffi cult to expectorate. By physical examination, T 39.3 °C and grayish complexion caused by acute disease with moderate anemia, exhaustion, normal consciousness, tachypnea, pale conjunctiva, and dry lips with no cyanochroia were observed. He also had symptoms of congested pharynx, decreased breath sounds in the right lower lung, and a large quantity of fi ne moist rales in both middle and lower lungs that are more obvious in the right lung. He had a history of contact to patients with infl uenza 

Infl uenza A (H1N1) complicated by pneumonia can be primary viral pneumonia or secondary bacterial pneumonia. In the initial stage, viral pneumonia occurs, which may develop into viral and bacterial mixed pneumonia or secondary bacterial pneumonia. Mild cases are characterized by interstitial pneumonia including lesions of intrapulmonary ground-glass opacity (GGO) distributing in lobes and segments. HRCT demonstrates thickened interlobular septa in reticular appearance. Severe cases demonstrate intrapulmonary diffusive GGO that is obvious in the middle and lower lung fi eld as well as obvious consolidation of gas cavity. HRCT demonstrations indicate interstitial changes and alveolar consolidation.

In the early stage (the fi rst 3 days after the onset), chest X-ray demonstrates thickened and blurry pulmonary markings and small patches of shadows, with the foci mostly located in the lower lung fi eld and around the hilum. Due to accompanying bronchiolitis, excessive pulmonary infl ation occurs. The progressing stage usually begins at day 4 after the onset, which is characterized by GGO and fl akes of parenchymal shadows. The multiple scattering foci integrate rapidly and progress into extensive lesions to involve multiple segments and lobes (Figs. 22.14 , 22.15 , 22.16 , 22.17 , 22.18 , and 22.19 ). In the convalescence stage, most of the foci are absorbed, possibly with residual cords or grid-shaped shadows and localized pulmonary emphysema. Bao et al. reported the fi ndings of residual pulmonary giant bullae in the convalescence stage, which may be caused by excessive ventilation of local lungs due to involved terminal bronchioles by infl ammation.

A male patient aged 18 years complained of fever for 3 days, cough for 2 days, and the highest body temperature of 38.5 °C. He also complained of headache, muscular pain, and mild cough with small quantity of yellowish purulent sputum. By physical examination, the pharynx was congested, tonsils were not enlarged, and moist rales were heard in both lungs. He had a history of contact to patients 

A male patient aged 37 years complained of fever and cough for 1 week. He also complained of coughing up whitish thick sputum and chest distress, with progressing conditions. Blood gas analysis indicated respiratory failure of type I. After admission, he was given an oxygen inhalation mask. By physical examination, T 39 °C, the pharynx was congested, and moist rales were heard in both lungs. He had a history of contact to patients with infl uenza A (H1N1 

A male patient aged 29 years, with complaints of cough for 7 days and fever for 6 days. He also complained of following wheezing and coughing up reddish foam liked sputum. By physical examination, T 40 °C, pharynx is congested, and moist rales were heard in both lungs. He denied history of contact to patients with infl uenza A (H1N1). Pharyngeal swab demonstrated positive M gene of infl uenza A (H1N1) virus, positive NP gene of swine infl uenza virus, and positive HA gene of infl uenza A (H1N1) virus. By routine blood test, WBC 17.89 × 10 9 /L, GR% 90.7 %, and LY% 5.5 %. By blood gas analysis, pH 7.33, PCO 2 54 mmHg, and PO 2 85 mmHg. By blood biochemistry, ALT 40 U/L, AST 32 U/L, Cr 115.9 μmol/L, and urea 16.73 mmol/L. 

A female patient aged 45 years complained of chill, fever, eye upset, and dry cough rarely with sputum for 5 days. She also complained of chest distress and suffocation. She was diagnosed with bronchitis by the physician from another hospital, with following medication of antiinfl ammatory drugs. After that, she developed chest distress and shortness of breath and was admitted to our hospital. By physical examination, T 39. 

In the early stage, HRCT demonstrates thickened bronchial vascular bundles and lobular consolidations that gradually fuse into large fl akes (Figs. 22.20 and 22.21 ) . In the progressing stage, HRCT demonstrates nodular shadows of lobular consolidation of central air cavities and multilobular or extensive GGO, possibly accompanied by localized consolidation shadow. With the continued progress of the conditions, GGO foci rapidly fuse and extend, possibly with increased density and fl akes of consolidation foci in or out of the GGO (Figs. 22.22 and 22.23 ) . In some cases, a small quantity of pleural effusion may be found. Agarwal et al. reported that 36 % of cases with severe infl uenza A (H1N1) infl uenza develop acute pulmonary embolism during hospitalization, which may be caused by high blood coagulation secondary to ARDS.

A female patient aged 18 years complained of fever and cough for 2 days, dyspnea, and vomiting for 1 day. By physical examination, the pharynx was congested and rough breathing sounds were heard in both lungs with moist rales. She had a history of close contact to patients with infl uenza By routine blood test, WBC 3.24 × 10 9 /L, GR% 57.74 %, and LY% 32.74 %. By blood biochemistry, TP 55 g/L, AST 100 U/L, ALT 69 U/L, CK 621 U/L, and LDH 511 U/L. During his hospitalization, he had persistent fever, coughed up sputum, and had chest distress. By auscultation, moist rales of both lungs can be heard that are more extensive in the right lung. 

A male patient aged 32 years complained of fever, cough, and pharyngalgia for 6 days, shortness of breath for 2 days, and the highest body temperature of 41 °C. He also reported cough with occasional small quantity of whitish foamy sputum and denied any history of contact to patients with infl uenza A (H1N1). After admission, his symptoms exacerbated, with severe cough and small quantity of pink foamy sputum. By physical examination, T 36.7 °C, bpm 107/min, R 25/min, BP 119/79 mmHg, SPO2 88 %, tonsils were enlarged in fi rst degree, and many moist rales in both lungs and dry rales in the right middle and lower lung were heard. Pharyngeal swab demonstrated positive M gene of infl uenza A (H1N1) virus, positive NP gene of swine infl uenza virus, and positive HA gene of infl uenza A (H1N1) virus. By routine blood test, WBC 8.2 × 10 9 /L and GR% 84.8 %. By blood gas analysis, pH 7.4, PCO 2 24.6 mmHg, PO 2 51 mmHg, BE −10 mmol/L and SO 2 87 %. By blood biochemistry, ALT 58 U In both early and progressing stages, ground-glass opacity is the most common manifestation. In the early stage, chest radiology demonstrates round-like ground-glass opacities distributing under the pleura or around the bronchial blood vessels, which is believed to be the characteristic demonstration of infl uenza A (H1N1). Ground-glass opacity is commonly complicated by pulmonary consolidation which may be located in the ground-glass opacity or independent of the ground-glass opacity. The ground-glass opacity can be morphological in patches and round-like nodular, localized, multifocal, and large fl akes of shadows, with uneven density and unclearly defi ned boundaries. The occurrence rate of ground-glass opacity is high, which is a rare sign in cases of other pneumonia.

At the center of the ground-glass opacity in the cases of infl uenza A (H1N1), lobular central nodules can also be found with empty cavities. The mechanism underlying the occurrence of empty cavities may be excessive pulmonary ventilation due to bronchostenosis caused by immune responses. These immune responses may be triggered by spreading of the virus into peribronchial tissues after its invasion into bronchial epithelial tissues.

The chest radiology of cases with severe infl uenza A (H1N1) complicated by ARDS is characterized by:

1. Various shapes of the lesions, including patches and large fl akes of consolidation shadows, fused patches of shadows or cloudy cotton-woollike shadows, and large fl akes of ground-glass opacity; in the cases with one lobe or multiple lobes involved, the density of pulmonary consolidation is even and uniform in white lung sign. 2. Multiple lobar infi ltration and migratory changes in the location and range of the lesions. 3. Both pulmonary parenchymal and interstitial involvements. 4. Rapid changes of imaging demonstrations. 5. Common occurrence of complications, including pneumothorax, mediastinal and subdermal edema (Figs. 22.24 and 22.25 ) , and even retroperitoneal pneumatosis and secondary fungal infection. In rare cases, local destruction and fi brosis of pulmonary tissues can be found, with honeycomb-like lung and insuffi cient pneumothoracic recruitment.

A male patient aged 19 years complained of fever for 6 days, dyspnea, and coughing up sputum for 5 days and the highest body temperature of 38 °C. He also had symptoms of coughing up yellowish thick sputum that is in small quantity, diffi cult to expectorate, and occasionally with blood and slight diffi culty in breathing. By physical examination, T 39 °C and the pharynx was congested. Pharyngeal swab demonstrated positive M gene of infl uenza A (H1N1) virus, positive NP gene of swine infl uenza virus, and positive HA gene of infl uenza A (H1N1) virus. He denied any history of contact to patients with infl uenza A (H1N1) or patients with infl uenza-like symptoms. By blood biochemistry, Myo 131 ng/L and CK-MB 7.68 ng/L. By blood gas analysis, pH 7.53, PCO 2 27.1 mmHg, and PO 2 52 mmHg. He was hospitalized due to the diagnosis of (1) severe and critical infl uenza A (H1N1), (2) severe pneumonia, (3) respiratory failure of type II and ARDS, and (4) 

A female patient aged 21 years complained of fever and cough for 9 days. She received anti-infl ammatory therapies, with conditions not improved. Her body temperature fl uctuated from 38 to 38.7 °C, with accompanying symptoms of chest distress, shortness of breath, and coughing up yellowish sputum. By physical examination, T 39.7 °C, the pharynx was congested, and tonsils were enlarged in fi rst degree. Moist rales can be heard in both lungs, which are absent after coughing. She had no defi nitive history of contact to patients with infl uenza A (H1N1). Pharyngeal swab demonstrated positive M gene of infl uenza A (H1N1) virus, negative NP gene of swine infl uenza virus, and positive HA gene of infl uenza A (H1N1) virus. By routine blood test, WBC 8.64 × 10 9 /L, GR% 76.14 %, and LY% 19.34 %. By blood biochemistry, CK 140 U/L and LDH 547 U/L. 

During pregnancy, pathophysiological changes of many acute or chronic pulmonary diseases are dramatic, leading to intolerance of pregnant women to obviously decreased pulmonary ventilation caused by pneumonia. During the gestational period, decreased total count of T helper lymphocytes and decreased activity of natural killer cells may result in susceptibility of pregnant women to viral and fungal pneumonia. Mild cases are characterized by ground-glass opacities and small fl akes and cotton-woollike high-density shadows in single or multiple pulmonary lobes. Severe cases are characterized by masses of cotton-woollike shadows and ground-glass opacity in multiple pulmonary lobes, with air bronchogram. Within 24 h, the conditions progress into diffuse high-density foci in both lungs, partially accompanied by atelectasis with possible complications of unilateral or bilateral pleuritis or pleural effusion and pericardial effusion (Figs. 22.26 and 22.27 ) . The mechanism underlying pleuritis remains elusive, which may be related to hypoproteinemia, direct viral actions, and endocrinological factors. Most of mild cases have favorable prognosis. But the conditions of severe cases may progress rapidly to cause ARDS, respiratory failure, cardiac failure and renal failure, septic shock, and even death from multiple organ failure.

A female patient aged 31 years complained of high fever, suffocation, and progressive diffi culty in breathing for 2 days which occurred at day 4 after Cesarean section. She also complained of coughing up pink foamy sputum and progressive dyspnea. After symptomatic therapies, her conditions failed to improve, but with rapid deterioration. By physical examination, T 40 °C and bpm 136/min, with oral lip cyanosis, rough breathing sound in both lungs, and overwhelming dry and moist rales in both lungs. She had a history of close contact to patients with infl uenza A (H1N1). Pharyngeal swab demonstrated negative M gene of infl uenza A (H1N1) virus, negative NP gene of swine infl uenza virus, and positive HA gene of infl uenza A (H1N1) virus. By routine blood test, WBC 12.97 × 10 9 /L and GR% 91.1 %. 

A female patient aged 27 years, at 37 +5 gestation, complained of fever for 7 days. She also complained of pharyngeal upset, general soreness and pain, and highest body temperature of 39.5 °C. In addition, frequent cough, pharyngalgia, diffi culty lying in supine position, and fl uctuation of body temperature between 38 and 39.5 °C occurred 6 days ago. She reported frequent fetal movement for 5 days, vaginal bleeding for 2 days, and decreased fetal movement for 1 day. She had a history of close contact to patients with infl uenza A (H1N1). Pharyngeal swab demonstrated positive M gene of infl uenza A (H1N1) virus, negative NP gene of swine infl uenza virus, and positive HA gene of infl uenza A (H1N1) virus. By routine blood test, WBC 5.25 × 10 9 /L, HGB 86 g/L, GR% 82.1 %, and LY% 16.4 %. By blood biochemistry, ALB 16 g/L and GLB 22.47 g/L. By blood gas analysis, pH 7.42, PCO 2 19.13 mmHg, PO 2 63 mmHg, and SO 2 95 %. 

A male patient aged 74 years complained of fever and cough for 4 days. By physical examination, T 39.4 °C, bpm 120/min, and R 24/min, with mental confusion and deep coma without any response to sound. The breathing sound of both lungs is low, with small quantity of moist rales in both basal lungs. After admission, he was given tracheal intubation connected to a respirator to assist his ventilation. He had a past history of hypertension and chronic bronchitis. Pharyngeal swab demonstrated positive viral nucleic acid of infl uenza A (H1N1). By routine blood test, WBC 9.51 × 10 9 /L and GR% 80.6 %. By blood gas analysis, pH 7.3, PO 2 144 mmHg, PCO 2 70 mmHg, HCO 3 − 33.4 mmol/L, BE 5.4 mmol/L, and SaO 2 98.8 %. By blood biochemistry, ALT 46.6 U/L, AST 56.3 U/L, TBIL 6.9 μmol/L, and Cr 85.6 μmol/L. 

A female patient aged 53 years complained of cough for 7 days and fever for 6 days with the highest body temperature of 40 °C. She also complained of wheezing and suffocating and coughing up pink foamy sputum. By physical examination, the pharynx was congested and moist rales were heard in both lungs. She denied a history of contact to patients with infl uenza A (H1N1). Pharyngeal swab demonstrated positive M gene of infl uenza A (H1N1) virus, positive NP gene of swine infl uenza virus, and positive HA gene of infl uenza A (H1N1) virus. By routine blood test, WBC 17.89 × 10 9 /L, GR% 90.7 %, and LY% 5.5 %. By blood gas analysis, pH 7.33, PCO 2 54 mmHg, and PO 2 85 mmHg. By blood biochemistry, ALT 81.3 U/L and AST 166.6 U/L. 

A female patient aged 22 years complained of fever for 6 days and tachypnea for 2 days with the highest body temperature of 39 °C. She also complained of chills, aversion to cold, cough with sputum, and cyanosis. She experienced spontaneous delivery of a baby boy 2 days ago. By physical examination, the pharynx was congested and diminished breath sounds in both lungs and densely distributed moist rales in both lower lungs were heard. She denied a history of contact to patients with infl uenza A (H1N1) and patients with infl uenza-like symptoms. By routine blood test, WBC 14.37 × 10 9 /L, HGB 73 g/L, and GR% 82 %. By blood gas analysis, pH 7.38, PCO 2 33 mmHg, and PO 2 66 mmHg. By blood biochemistry, ALT 330 U/L, AST 2650 U/L, ALB 23.7 g/L, Cr 58.9 μmol/L, and urea 2.49 mmol/L. She was given antiinfection therapy after her admission and noninvasive use of respirator to assist ventilation. However, her conditions exacerbated and death occurred due to respiratory failure. 

The diagnosis can be defi ned based on epidemiological history, clinical manifestations, and etiological examinations. Early detection and early diagnosis play critical role in controlling and curing infl uenza A (H1N1).

A case can be suspected with infl uenza A (H1N1) with at least one of the following conditions:

1. A history of close contact to defi nitive case of infl uenza A (H1N1) that is in the infective stage within 7 days before the onset of fl u-like symptoms; a close contact refers to diagnosing, treating, and attending patients with infl uenza A (H1N1) in the infective stage with no effective protection, living together with the patient, and contact to respiratory secretion or body fl uid of the patient. 2. Onset of infl uenza-like clinical manifestations, with infl uenza A (H1N1) virus positive but no further examination to defi ne the viral subtype.

For the cases with at least one of the above two conditions, etiological examinations should be performed to defi ne the diagnosis.

Clinical diagnosis can be made based only on the following conditions. The cases have infl uenza-like symptoms but with no defi nitive diagnosis by laboratory tests and examinations in one the same prevailing event of infl uenza A (H1N1). When other diseases causing infl uenza-like symptoms are excluded, the cases can be clinically diagnosed with infl uenza A (H1N1).

Infl uenza A (H1N1) can be defi ned as the presence of infl uenza-like clinical manifestations, along with one or more of the following laboratory fi ndings: (1) viral nucleic acid of infl uenza A (H1N1) virus positive by real-time RT-PCR and RT-PCR; (2) successful isolation of infl uenza A (H1N1) virus; and (3) at least four times increase of specifi c antibody against infl uenza A (H1N1) virus in double sera.

The cases with one of the following conditions can be defi ned as severe: (1) high fever persisting for at least 3 days and accompanying severe cough with thick sputum, bloody sputum, or chest pain; (2) increased frequency of respiration, dyspnea, and cyanosis of oral lips; (3) conscious changes with sluggish response, lethargy, irritation, and convulsion;

(4) severe vomiting and diarrhea with dehydration; (5) complication of pneumonia; and (6) obviously exacerbated previous basic diseases.

The cases with one of the following conditions can be defi ned as critical: (1) respiratory failure, (2) infective toxic shock, (3) multiple organ dysfunction, and (4) other severe clinical conditions requiring intensive care.

X-ray and CT scanning demonstrate patches of exudative shadow, network of shadow, and nodular shadow in both lungs that are more common in the lower lungs. The conditions may progress, with demonstrations of large fl akes of consolidation shadow.

There are multifocal and symmetric cerebral lesions, involving the bilateral thalamus, tegmentum of the brainstem, white matter around the cerebral ventricles, and medulla of the cerebellum. CT scanning demonstrates low-density shadow of the lesions. MR imaging demonstrates long T1 and long T2 signals.

Reye syndrome is an acute encephalopathy accompanied by hepatic fatty degeneration. After viral infection, symptoms of encephalopathy commonly occur, including acute intracranial hypertension, conscious disturbance, and convulsion. Accompanying hepatic dysfunction also occurs. By biochemistry, serum transaminase increases in different degrees, as well as increased blood ammonia and decreased blood sugar. By diagnostic imaging, the main demonstration is the sign of diffuse cerebral edema, rarely with brain parenchymal lesions. Reye syndrome is so dangerous that it can cause death within 24 h. But most survivors experience improved conditions after 2-3 days.

Epidemic encephalitis B is transmitted by mosquitoes, with common occurrence in summers and in children under the age of 10 years. Clinically, it is characterized by high fever, spasm, conscious disturbance, and meningeal irritation sign.

By laboratory examinations, increased WBC count can be found in both cerebrospinal fl uid examination and routine blood test that are mainly neutrophilic granulocytes. Serological specifi c IgM antibody can be detected 3-4 days after the onset. By diagnostic imaging, the lesions can involve the thalamus, cerebral cortex, and spinal cord, with an asymmetric distribution and rare involvement of the brainstem.

Autosomal dominant acute necrotizing encephalopathy is a disease with incomplete genetic penetrance, with its genes being located in 2q12.1-2q13. Its pathological foundation is loss of coupling due to mitochondrial oxidative phosphorylation. Autosomal dominant acute necrotizing encephalopathy commonly occurs in children and is characterized by sudden encephalopathy symptoms 2-3 days after the onset of febrile illness. By diagnostic imaging, lesions are symmetrically distributed in the thalamus and brainstem, being similar to those of ANE. Autosomal dominant acute necrotizing encephalopathy tends to relapse which can cause more serious lesions.

Infl uenza A (H1N1) complicated by pneumonia has similar imaging demonstrations to other pneumonia, especially viral pneumonia. The defi nitive diagnosis is based on epidemiological history and laboratory detection for specifi c virus. Meanwhile, some patients develop pneumonia before their infection of infl uenza A (H1N1). For these cases, differential diagnosis should be made for defi nitive diagnosis.

Adenoviral pneumonia, a common viral pneumonia, commonly occurs in children. It is characterized by peritracheitis, peribronchitis, and alveolitis. X-ray demonstrates thickened and blurry pulmonary markings and pulmonary exudative shadow, commonly with accompanying emphysema. Adenoviral pneumonia rarely develops into respiratory failure and can be effectively treated by antiviral therapies. Its course lasts for a short period of time.

Mycoplasma pneumonia is pneumonia with interstitial changes caused by mycoplasma. In the early stage, mycoplasma pneumonia is characterized by imaging demonstrations of increased and blurry pulmonary markings and network of markings. During the progressing stage, the markings are demonstrated as localized or extensive fl akes of blurry shadows and large fl akes of fanlike shadows stretching from the hilum to exterior lung fi elds, which are distributed in pulmonary lobes or segments. Such a distribution can also be absent. CT scanning demonstrates early pulmonary interstitial infl ammation, network of shadow, and thickened interlobular septum.

Allergic pneumonia is characterized by rapid changes of pulmonary demonstrations and foci, which is the same as severe and critical cases of infl uenza A (H1N1) complicated by pneumonia. However, the main pathological changes of allergic pneumonia are exudative alveolitis and interstitial pneumonia with light and thin pulmonary shadows. After clinical treatment, the foci are rapidly absorbed and their onset is related to allergens, which should be taken into account for differentiation.

SARS, severe acute respiratory syndrome, is also known as infectious atypical pneumonia and is caused by coronavirus.

In the early stage, X-ray and CT scanning demonstrate small fl akes of shadows in the lungs. In the progressing stage, the small fl akes of shadows progress into large fl akes or diffuse shadows, possibly complicated by pulmonary consolidation.

Being the same as severe infl uenza A (H1N1) complicated by pneumonia, SARS has a long course, whose differentiation should be based on etiological examinations. However, the imaging demonstrations are different between the two diseases due to different therapies. Infl uenza A (H1N1) complicated by pneumonia is commonly treated by antiviral therapies, with rare occurrence of intrapulmonary interstitial hyperplasia during the course and in the prognostic outcomes. However, the use of hormone in treating SARS causes obvious intrapulmonary interstitial hyperplasia in patients, with prognostic interstitial hyperplasia or interstitial fi brosis.

Chest radiographic and CT fi ndings in novel swine-origin infl uenza A(H1N1)virus infection

Image demonstrations of severe and critical infl uenza A (H1N1) complicated by pneumonia

Clinical guideline for infl uenza A (H1N1) (2010 edition). China: Administrative Offi ce of the Ministry of Health

A new cause of cavitated bilateral pulmonary nodules: infl uenza A (H1N1) virus

MR imaging in novel infl uenza A (H1N1)-associated meningoencephalitis

infl uenza virus infection during pregnancy in the USA

Radiology of infl uenza A (H1N1)-basics and clinical practice

Radiology of infl uenza A(H1N1

A case of infl uenza A (H1N1) complicated by pneumonia

Imaging demonstrations and pathological analysis of critical infl uenza A (H1N1) complicated by pneumonia

Critical infl uenza (H1N1) pneumonia: imaging manifestations and histopathological fi ndings

Acute necrotizing encepH alopathy in a child with H1N1 infl uenza infection

Acute necrotizing encepH alopathy progressing to brain death in a pediatric patient with novel infl uenza A (H1N1) infection

Acute necrotizing encepH alopathy in a child during the 2009 infl uenza A(H1N1) pandemia: MR imaging in diagnosis and follow-up

Pandemic H1N1 2009 infl uenza a virus induces weak cytokine responses in human macropH ages and dendritic cells and is highly sensitive to the antiviral actions of interferons

Imaging demonstrations of infl uenza A (H1N1) complicated by pneumonia: case report of 56 cases

Pathological changes associated with the 2009 H1N1 virus

Pediactric cases report on infl uenza A (H1N1) complicated by neurological complications during the pandemic of infl uenza A (H1N1) in 2009

Image demonstrations of infl uenza A (H1N1) complicated by acute respiratory distress syndrome

Imaging demonstrations of pediatric critical infl uenza A (H1N1) complicated by neurological complications